Hadassah

Kidney Donor With Hepatitis C Enables Hadassah Patient to Thrive

Tuesday, Jul 31 2018

Shuki Mizrachi has a rare genetic disease that causes his kidneys to fail. At age 42, he had already undergone years of dialysis and three kidney transplants. His body was no longer able to undergo dialysis and there were no healthy kidneys available for transplant.

That’s when Hadassah Medical Organization nephrologist Dr. Keren Tzukert offered Mr. Mizrachi a chance to be the first Israeli patient to receive a kidney from a donor with Hepatitis C. “When you are drowning and someone offers you a life raft, you take it--even if there is a small hole,” Mr. Mizrachi says.

Mr. Mizrachi received antiviral medications to combat the Hepatitis C immediately following his transplant. A year later, he is still healthy, with no sign of hepatitis and a functioning kidney.

Hadassah was one of the first medical centers in the world to perform an organ transplant from a donor with hepatitis. “The success of antiviral medications in combating Hepatitis C made such transplants a viable option,” explains Prof. Rifaat Safadi, head of Hadassah’s Liver Unit. “Without these medications, we would have had to reject these kidneys. Now they can save our patients’ lives.”

To date, three additional patients have received kidneys from Hepatitis C positive donors at Hadassah.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Jun 19 2019

Happiness in the Intensive Care Unit: A Father Expresses His Anticipatory Joy

“My name is Yoel Fadel. Today is a very special day for me. My youngest son, Benny, is getting married. He will walk to the wedding canopy with his sweetheart, but I cannot attend the wedding.

READ MORE ›
alt_text

Wednesday, Jun 19 2019

Helping with a Full Heart: A Mitzvah Passed on at Hadassah Mount Scopus

They met in the Pediatrics Department at Hadassah Hospital Mount Scopus, two couples whose children suffer from a rare disease.

READ MORE ›
alt_text

Tuesday, Jun 18 2019

Diabetes: An Ongoing Struggle

Prof. Gil Leibowitz, head of the Diabetes Unit at the Hadassah Medical Organization’s Endocrinology and Metabolism Service, remembers himself as a scared, skinny seven-year-old when the doctor told his parents that he had type 1 diabetes.

READ MORE ›
alt_text

Wednesday, Jun 12 2019

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

In a large multinational study that revealed the effectiveness of a medicine called dapagliflozin in reducing cardiovascular death from heart failure among high-risk diabetic patients, the first sub-analysis of renal data has also identified a 47 percent drop in decline of kidney function and renal death.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More